Biologic Drugs

Oct 12, 2018
By Pharmaceutical Technology Editors
The company says the new equipment will reduce sample turnaround times and increase variant detection quality and accuracy.
Oct 12, 2018
By Pharmaceutical Technology Editors
A new investigational vaccine, LASSARAB, shows promise for use against Lassa fever and rabies.
Oct 12, 2018
By Pharmaceutical Technology Editors
Novartis’ Sandoz has reached a global patent resolution for Hyrimoz (adalimumab), its biosimilar to AbbVie’s Humira (adalimumab).
Oct 05, 2018
By Pharmaceutical Technology Editors
Advances in biologic drug development require increased methodological and technological innovation from the biopharma industry. Learn more at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.
Sep 28, 2018
While food, shelter, and clothing are the primal essentials for life, hope—as embodied by modern medicine—has now become part of that human expectation.
Sep 28, 2018
By Pharmaceutical Technology Editors
CPhI releases the bio trends portion of its annual report, which predicts an increase in bioconjucation expertise and biopharma productivity over the next five years.
Sep 25, 2018
By Pharmaceutical Technology Editors
Cell-line quality has a significant impact on biologic drug quality; learn more about this and other upstream challenges at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.
Sep 21, 2018
By Pharmaceutical Technology Editors
The European Medicines Agency has recommended Luxturna (voretigene neparvovec) as the first treatment option for hereditary retinal dystrophy with mutations of the RPE65 gene.
Sep 20, 2018
By Pharmaceutical Technology Editors
The CHF 400-million (US$416-million) investment in Lonza's biopark in Visp, Switzerland, will expand Ibex Solutions with two new offerings, drug substance development and drug substance and drug product manufacturing.
Sep 13, 2018
By Pharmaceutical Technology Editors
The collaboration will focus on developing manufacturing solutions for biosimilars.
native1_300x100
lorem ipsum